Evidence map›Paper›PMID 28507520›Full record

ArticleFrontiers in pharmacology2017

Adnan Amin, Emmy Tuenter, Kenn Foubert, Jamhsed Iqbal, Paul Cos, Louis Maes, Vassiliki Exarchou, Sandra Apers, Luc Pieters

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Adnan AminLaboratory of Natural Products and Food Research and Analysis, Department of Pharmaceutical Sciences, University of AntwerpAntwerp, Belgium.
Emmy TuenterLaboratory of Natural Products and Food Research and Analysis, Department of Pharmaceutical Sciences, University of AntwerpAntwerp, Belgium.
Kenn FoubertLaboratory of Natural Products and Food Research and Analysis, Department of Pharmaceutical Sciences, University of AntwerpAntwerp, Belgium.
Jamhsed IqbalCentre for Advanced Drug Research, COMSATS Institute of Information TechnologyAbbottabad, Pakistan.
Paul CosLaboratory of Microbiology, Parasitology and Hygiene, Faculty of Pharmaceutical, Biomedical and Veterinary Sciences, University of AntwerpAntwerp, Belgium.
Louis MaesLaboratory of Microbiology, Parasitology and Hygiene, Faculty of Pharmaceutical, Biomedical and Veterinary Sciences, University of AntwerpAntwerp, Belgium.
Vassiliki ExarchouLaboratory of Natural Products and Food Research and Analysis, Department of Pharmaceutical Sciences, University of AntwerpAntwerp, Belgium.
Sandra ApersLaboratory of Natural Products and Food Research and Analysis, Department of Pharmaceutical Sciences, University of AntwerpAntwerp, Belgium.
Luc PietersLaboratory of Natural Products and Food Research and Analysis, Department of Pharmaceutical Sciences, University of AntwerpAntwerp, Belgium.
University of Antwerp · BECOMSATS University Islamabad · PK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antiglycation activityantimicrobial activityiridoidsKickxia ramosissimaNanorrhinum ramosissimumPlantaginaceae

Identifiers

PMID28507520
PMCPMC5410595
OpenAlexW2611089144

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.